Join Now

Author Archives: Press Release

BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System

By Press Release | Published July 27, 2023

BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that includes large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, auto-identification, dose error reduction software and EMR interoperability BD Alaris™ Infusion System’s unique “One System” platform securely connects all patient modules to provide care teams […]

Posted in BioUtah News | Tagged | Comments Off on BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System

Renalytix Announces Middle East Distribution Agreement with Vector Pharma

By Press Release | Published July 27, 2023

Distribution agreement opens kidneyintelX.dkd testing to address early-stage kidney disease in region with one of the highest incidence rates for type 2 diabetes globally

Posted in BioUtah News | Tagged | Comments Off on Renalytix Announces Middle East Distribution Agreement with Vector Pharma

CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA

By Press Release | Published June 29, 2023

Three separate teams of physician scientists at UCLA working on three different parts of the project have made significant progress and are ready to merge their work into a complete proof-of-concept vaccine construct

Posted in BioUtah News | Tagged | Comments Off on CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA

Ultradent Adds New Cordless Prophy Handpiece

By Press Release | Published June 29, 2023

Ultradent Products, Inc. is announcing the addition of the Ultrapro™ Tx Cordless handpiece to its prestigious Ultrapro™ Tx prophylaxis family

Posted in BioUtah News | Tagged | Comments Off on Ultradent Adds New Cordless Prophy Handpiece

CLENE ANNOUNCES PUBLICATION OF PHASE 2 CNM-AU8® CLINICAL DATA FOR THE TREATMENT OF ALS IN LANCET’S ECLINICALMEDICINE

By Press Release | Published June 29, 2023

Peer-reviewed publication includes data from the CNM-Au8 Phase 2 RESCUE-ALS trial and its open-label-extension, up to 120 weeks of patient follow-up

Posted in BioUtah News | Tagged | Comments Off on CLENE ANNOUNCES PUBLICATION OF PHASE 2 CNM-AU8® CLINICAL DATA FOR THE TREATMENT OF ALS IN LANCET’S ECLINICALMEDICINE

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

By Press Release | Published June 29, 2023

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

Posted in BioUtah News | Tagged | Comments Off on Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray

By Press Release | Published June 29, 2023

Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray

Posted in BioUtah News | Tagged | Comments Off on Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray

CancerVAX Reports Positive Progress on Kids Cancer Immunotherapy Treatment

By Press Release | Published June 15, 2023

UCLA research team has successfully created 7 pre-clinical monoclonal antibody candidates for targeting Ewing sarcoma

Posted in BioUtah News | Tagged | Comments Off on CancerVAX Reports Positive Progress on Kids Cancer Immunotherapy Treatment

FDA Issues Final Guidance on Content of Premarket Submissions for Device Software Functions

By Press Release | Published June 15, 2023

On June 13, the U.S. Food and Drug Administration (FDA) issued the final guidance: Content of Premarket Submissions for Device Software Functions. The final guidance provides information regarding the recommended documentation sponsors should include in premarket submissions for the FDA’s evaluation of the safety and effectiveness of device software functions. The guidance replaces the FDA’s […]

Posted in BioUtah News, Federal News | Comments Off on FDA Issues Final Guidance on Content of Premarket Submissions for Device Software Functions

Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

By Press Release | Published June 14, 2023

Recursion’s small molecule is the first therapeutic candidate to be advanced to an industry-sponsored Phase 2 clinical trial for cerebral cavernous malformation (CCM). CCM is a devastating neurovascular disease with approximately 360,000 symptomatic patients in the United States and EU5.

Posted in BioUtah News | Tagged | Comments Off on Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

By Press Release | Published June 14, 2023

Myriad to support MD Anderson researchers studying metastatic renal cell carcinoma treatment selection and response

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

Vistim Labs Closes First Round of Funding

By Press Release | Published May 11, 2023

Vistim Labs Closes First Round of Funding

Posted in BioUtah News | Tagged | Comments Off on Vistim Labs Closes First Round of Funding

A Special Thanks To Our Elite Members